FKBP1A and neoplasm: Although there are reports showing that FKBP12 can stimulate oncoprotein mouse double minute 2 (MDM2) self-ubiquitination and degradation to enhance the sensitivity in breast cancer cells and chemotherapy [12,13], its prognostic value and association with tumor immunity in LIHC have not been clearly defined.